GLP1R and hypertensive disorder: Similar studies have been done in the past, A 2022 retrospective cohort study reported longer use and higher dose of GLP-1 RAs were associated with a decreased risk of hospitalization for ischemic stroke among Asian patients with T2DM who did not have established atherosclerotic cardiovascular diseases, but who did have dyslipidemia or hypertension (20).